Article
COVID-19 Vaccine Hesitancy Among Parents of Children Under Five Years in the United States
2022-08-02
Abstract excerpt
On 17 June 2022, the U.S. FDA authorized the Pfizer-BioNTech and Moderna COVID-19 (SARS-CoV-2) vaccines for emergency use in children ages 6 months – 4 years. Seroprevalence has increased during the current Omicron variant wave for children under 5 years and the burden of hospitalization for this age group is similar or exceeds other pediatric vaccine preventable diseases. Research following the October 2021 appro...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 93248d11-f8bc-5309-bb4d-a373a591a238
- DOI
- 10.20944/preprints202208.0055.v1
